Abstract:Background: Chronic limb-threatening ischemia (CLTI), which presents with ischemic rest pain, ulceration, or gangrene, is a complex form of peripheral artery disease that can cause mortality and amputation. C-reactive protein (CRP), an inflammatory marker, indicates vascular inflammation resulting from the cytokine-dependent inflammatory process in the arterial wall, and arterial atherosclerosis resulting from the inflammation. Lower albumin levels are also associated with peripheral artery disease. We investigated the association between CRP/Albumin ratio (CAR) and long-term mortality in patients with CLTI. Methods: A total of 172 patients who underwent endovascular treatment (EVT) for below the knee (BTK) lesions were enrolled in this study. Patients with acute infection requiring antibiotic therapy, chronic inflammatory disease, end-stage liver disease, malignancy were excluded from the study. Besides, patients with pre-follow-up intervention to the same vascular bed were also excluded from the study. The primary endpoint of the study was all-cause mortality. Patients were divided into 2 groups according to mortality. Results: A total of 70 patients (40.6%) died during 32 ± 21 months of follow-up in the present study. The major amputation rate was 21.5%. The mortality (+) group was older and had higher rates of congestive heart failure, chronic kidney disease, history of stroke, and CRP levels. Moreover, statin and ACE inhibitor/angiotensin receptor blocker (ACE/ARB) use, GFR, and albumin levels were lower in the mortality (+) group. CAR was significantly higher in the mortality (+) group when comparing both groups (3.25 [1.46 - 7.86] vs. 9.75 [4.5 - 17.71], P < 0.001). CAR, congestive heart failure, chronic kidney disease, history of stroke, ACE/ARB, or statin use were independent predictors of all-cause mortality in multivariable Cox regression analysis. Conclusions: CAR was associated with mortality in CLTI patients undergoing EVT for BTK lesions. CAR may be a simple method to help patient selection, assessment, and intervention strategy for EVT and may improve patient outcomes.

Preoperative Albumin and Postoperative CRP/Albumin Ratio (CARS) are Independent Predictive Factors in Estimating 1-Year Mortality in Patients Operated for Proximal Femoral Metastasis with Endoprosthesis

Preoperative C-reactive Protein/albumin Ratio to Predict Mortality and Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.

Prognostic value of C-reactive protein to albumin ratio for mortality in acute kidney injury

Postoperative Ratio of C-Reactive Protein to Albumin As a Predictive Marker in Patients with Crohn’s Disease Undergoing Bowel Resection

C-reactive Protein/Albumin Ratio As a Prognostic Indicator in Posttraumatic Shock and Outcome of Multiple Trauma Patients

Association between Preoperative C-Reactive Protein-to-Albumin Ratio and Mortality after Plastic and Reconstructive Surgery

Preoperative C-reactive protein-to-albumin ratio and clinical outcomes after resection of colorectal liver metastases

Preoperative C-reactive protein/albumin ratio and mortality of off-pump coronary artery bypass graft

Preoperative High C-Reactive Protein to Albumin Ratio Predicts Short- and Long-Term Postoperative Outcomes in Elderly Gastric Cancer Patients

Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study.

Preoperative and Postoperative C-Reactive Protein to Albumin Ratio (CAR) as a Prognostic Marker for Survival of Esophageal Squamous Cell Carcinoma Patients After Surgery

Association Between CRP/Albumin Ratio and Long-Term Mortality in Patients With cHronIc Limb-Threatening Ischemia Undergoing EndovaScular Therapy Below The Knee: The ACHILES-BTK Registry

Association between inflammation-based prognostic markers and mortality after hip replacement

Prognostic Value of the Fibrinogen/albumin Ratio (FAR) in Patients with Operable Soft Tissue Sarcoma

Prognostic Significance of Preoperative C-reactive Protein: Albumin Ratio in Patients with Clear Cell Renal Cell Carcinoma.

Prognostic importance of preoperative albumin-to-alkaline phosphatase ratio in colorectal cancer patients

Prognostic Value Of The C-Reactive Protein/Albumin Ratio And Systemic Immune-Inflammation Index For Patients With Colorectal Liver Metastasis Undergoing Curative Resection

C-reactive protein to albumin ratio may predict in-hospital mortality in non-ST elevation myocardial infarction

Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients

Pretreatment C‐reactive Protein/albumin Ratio is Associated with Poor Survival in Patients with Stage IB‐IIA Cervical Cancer

Preoperative C-reactive protein/albumin ratio predicts outcome of surgical papillary renal cell carcinoma.